Authors:
Casassus, P
Gibson, J
Joshua, DE
Matthews, J
Diaz, JC
Gertz, MA
Kyle, R
Leong, T
Oken, MM
Fritz, E
Ludwig, H
Corrado, C
Lastiri, F
Peest, D
Grosbois, B
Vela-Ojeda, J
Avvisati, G
Mandelli, F
Petrucci, MT
Capnist, G
Child, JA
Drayson, MT
Dunn, J
MacLennan, I
Mellstedt, H
Osterborg, A
Rodjer, S
Turesson, I
Westin, J
Bergsagel, D
Browman, GP
Shustik, C
Zee, B
Hjorth, M
Holmberg, E
Rodjer, S
Turesson, I
Westin, J
Alison, R
Clarke, M
Elphinstone, P
Evans, V
Gray, R
Hicks, C
James, S
MacKinnon, L
Peto, R
Richards, S
Wheatley, K
Blade, J
Fontanillas, M
San Miguel, J
Aitchison, R
Newland, AC
Cunningham, D
Malpas, J
Powles, RL
Montuoro, A
Jacobson, J
Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
Authors:
Giordani, A
Haigle, J
Leflon, P
Risler, A
Salmon, S
Aubailly, M
Maziere, JC
Santus, R
Morliere, P
Citation: A. Giordani et al., Contrasting effects of excess ferritin expression on the iron-mediated oxidative stress induced by tert-butyl hydroperoxide or ultraviolet-A in humanfibroblasts and keratinocytes, J PHOTOCH B, 54(1), 2000, pp. 43-54
Authors:
Nelson, MA
Radmacher, MD
Simon, R
Aickin, M
Yang, JM
Panda, L
Emerson, J
Roe, D
Adair, L
Thompson, F
Bangert, J
Leong, SPL
Taetle, R
Salmon, S
Trent, J
Citation: Ma. Nelson et al., Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases, CANC GENET, 122(2), 2000, pp. 101-109
Authors:
Rimsza, LM
Campbell, K
Dalton, WS
Salmon, S
Willcox, G
Grogan, TM
Citation: Lm. Rimsza et al., The major vault protein (MVP), a new multidrug resistance associated protein, is frequently expressed in multiple myeloma, LEUK LYMPH, 34(3-4), 1999, pp. 315
Citation: S. Salmon et Jf. Ponge, Distribution of Heteromurus nitidus (Hexapoda, Collembola) according to soil acidity: interactions with earthworms and predator pressure, SOIL BIOL B, 31(8), 1999, pp. 1161-1170
Authors:
Pasquali, S
Maqueo, JD
Vela, J
Kyle, RA
Leong, T
Fritz, E
Suciu, S
Palva, IP
Oivanen, T
Corrado, C
Lastiri, FJ
Peest, D
Kildahl-Andersen, O
Maniatis, A
Alison, R
Clarke, M
Evans, V
Gray, R
Greaves, E
Hall, E
Hicks, C
James, S
Peto, R
Richards, S
Sinclair, D
Tooth, A
Wheatley, K
Avvisati, G
Boccadoro, M
Bugliosi, R
Mandelli, F
Petrucci, MT
Pileri, A
Tribalto, M
Alexanian, R
Delasalle, KB
Child, J
Dunn, J
MacLennan, I
Milligan, D
Mellstedt, H
Osterborg, A
Hjorth, M
Holmberg, E
Rodjer, S
Westin, J
Kamiya, O
Shimizu, K
Bergsagel, DE
Shustik, C
Hippe, E
Kjaersgaard, E
Turesson, I
Westin, J
Riccardi, A
Ucci, G
Blade, J
Fontanillas, M
De Rosa, L
Montuoro, A
Bartolucci, AA
Omura, GA
Stagg, M
Salmon, S
Tangen, C
Jacobs, P
Wood, L
Levy, LM
Citation: S. Pasquali et al., Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials, J CL ONCOL, 16(12), 1998, pp. 3832-3842